Trials / Completed
CompletedNCT00374582
End Stage Liver Disease and Body Composition Assessment: Utilizing Bioelectric Impedance Analysis (BIA)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- University of Cincinnati · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to see how effective bioelectric impedance analysis (BIA) is in determining body composition (the amount of fat versus muscle in the body) and nutritional status in patients with End Stage Liver Disease (ESLD)
Detailed description
The aim of this study is to report the validity of mBIA to determine body composition changes pre and post LVP (Large Volume Paracentesis) * 18 years of age or older * Cirrhotic patients with refractory ascites requiring LVP (a treatment to remove large volumes of excess fluid from the abdominal cavity) * End Stage Liver Disease
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Bodystat Quadscan 4000 | device determining body composition and nutritional status |
| DEVICE | bodystat quadscan 400 | device determining body composition and nutritional status |
Timeline
- Start date
- 2006-09-01
- Primary completion
- 2008-05-01
- Completion
- 2008-05-01
- First posted
- 2006-09-11
- Last updated
- 2011-03-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00374582. Inclusion in this directory is not an endorsement.